BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25215905)

  • 1. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer.
    Li J; Kong F; Wu K; Song K; He J; Sun W
    Mol Med Rep; 2014 Nov; 10(5):2613-20. PubMed ID: 25215905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
    Xie C; Jiang XH; Zhang JT; Sun TT; Dong JD; Sanders AJ; Diao RY; Wang Y; Fok KL; Tsang LL; Yu MK; Zhang XH; Chung YW; Ye L; Zhao MY; Guo JH; Xiao ZJ; Lan HY; Ng CF; Lau KM; Cai ZM; Jiang WG; Chan HC
    Oncogene; 2013 May; 32(18):2282-91, 2291.e1-7. PubMed ID: 22797075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
    Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
    Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
    Li J; Hu GH; Kong FJ; Wu KM; He B; Song K; Sun WJ
    Neoplasma; 2014; 61(2):144-52. PubMed ID: 24299310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.
    Hu H; Li S; Liu J; Ni B
    Acta Biochim Biophys Sin (Shanghai); 2012 May; 44(5):424-30. PubMed ID: 22491710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
    Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
    Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.
    Iwamoto N; Vettori S; Maurer B; Brock M; Pachera E; Jüngel A; Calcagni M; Gay RE; Whitfield ML; Distler JH; Gay S; Distler O
    Ann Rheum Dis; 2016 Jan; 75(1):303-10. PubMed ID: 25384965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Hashemi ZS; Forouzandeh Moghadam M; Khalili S; Ghavami M; Salimi F; Sadroddiny E
    Breast Cancer; 2019 Mar; 26(2):215-228. PubMed ID: 30284194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
    Zhu L; Chen Y; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
    Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
    Jin X; Sun Y; Yang H; Li J; Yu S; Chang X; Lu Z; Chen J
    PLoS One; 2015; 10(4):e0125515. PubMed ID: 25905463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis.
    Mitra AK; Chiang CY; Tiwari P; Tomar S; Watters KM; Peter ME; Lengyel E
    Oncogene; 2015 Nov; 34(48):5923-32. PubMed ID: 25798837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-216a may inhibit pancreatic tumor growth by targeting JAK2.
    Hou BH; Jian ZX; Cui P; Li SJ; Tian RQ; Ou JR
    FEBS Lett; 2015 Aug; 589(17):2224-32. PubMed ID: 26149212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
    Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
    Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
    Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.